Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
TAPENTADOL DOSE CONVERSION CHART Doses in this conversion chart are approximate equivalent doses only. Caution is always necessary. It should be noted that these equivalent doses relate to analgesic equivalence and not opioid equivalence due to the dual mechanism of action of tapentadol (mu-opioid receptor agonist and noradrenaline reuptake inhibitor). When converting from one strong opioid to another it is important to: take account of the clinical condition of the patient; consider a dose reduction; review after 24 hours and titrate accordingly. Route of administration Oral Drug Equivalent Doses Morphine total daily dose Tapentadol(1) total daily dose Oxycodone total daily dose 40mg<=> 80mg<=> 120mg<=> 160mg<=> 200mg<=> 100mg<=> 200mg<=> 300mg<=> 400mg<=> 500mg<=> 20mg<=> 40mg<=> 60mg<=> 80mg<=> 100mg<=> (1) Tapentadol m/r is restricted to patients unable to tolerate morphine m/r under the direction of the Pain Clinic. Total daily doses of tapentadol greater than 500mg have not been studied and are therefore not recommended. Opioid Formulations and Strengths Preparations Liquid Morphine (oral) 10mg/5mL oral solution Tapentadol (oral) 100mg/5mL concentrated oral solution Immediate Release Modified Release 10mg, 20mg, 50mg tablets 12-hourly tablets: 5mg, 10mg, 15mg, 30mg, 60mg, 100mg, 200mg Oxycodone (oral) 5mg/5mL oral solution 10mg/1mL concentrated oral solution Not recommended - 50mg and 75mg tablets are available but not approved by SMC.* 5mg, 10mg, 20mg capsules 12-hourly tablets: 50mg, 100mg, 150mg, 200mg, 250mg 12-hourly tablets: 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 60mg, 80mg, 120mg 12-hourly suspension (sachet of granules to mix with water): 20mg, 30mg, 60mg, 100mg, 200mg *Tapentadol immediate release can only be used under specialist direction where an Individual Patient Treatment Request (IPTR) has been approved. Caution: tapentadol immediate-release tablets do not allow an appropriate breakthrough dose at total daily doses of tapentadol below 300mg. Reference: Personal communication. Grunenthal Ltd. 18/10/11.